Balance Sheet
Accounts PayablesAccumulated DepreciationAccumulated ExpensesAssetsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesLiabilities and Shareholders EquityNon-Current AssetsNon-Current Deffered RevenueOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Retained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Beam Therapeutics (BEAM) Long-Term Investments: 2020

Historic Long-Term Investments for Beam Therapeutics (BEAM) over the last 1 years, with Dec 2020 value amounting to $2.6 million.

  • Beam Therapeutics' Long-Term Investments was N/A to $24.5 million in Q3 2021 from the same period last year, while for Sep 2021 it was $24.5 million, marking a year-over-year change of. This contributed to the annual value of $2.6 million for FY2020, which is N/A change from last year.
  • Per Beam Therapeutics' latest filing, its Long-Term Investments stood at $2.6 million for FY2020.
  • Over the past 5 years, Beam Therapeutics' Long-Term Investments peaked at $2.6 million during FY2020, and registered a low of $2.6 million during FY2020.
  • Moreover, its 1-year median value for Long-Term Investments was $2.6 million (2020), whereas its average is $2.6 million.